Rosás-Umbert, Miriam http://orcid.org/0000-0002-2850-6586
Gunst, Jesper D. http://orcid.org/0000-0002-3787-0259
Pahus, Marie H. http://orcid.org/0000-0003-0776-3847
Olesen, Rikke
Schleimann, Mariane http://orcid.org/0000-0001-5147-9523
Denton, Paul W. http://orcid.org/0000-0003-2458-8147
Ramos, Victor
Ward, Adam http://orcid.org/0000-0002-7038-5597
Kinloch, Natalie N.
Copertino, Dennis C. http://orcid.org/0000-0002-3217-4713
Escribà, Tuixent http://orcid.org/0000-0001-9467-7802
Llano, Anuska http://orcid.org/0000-0002-0133-9888
Brumme, Zabrina L. http://orcid.org/0000-0002-8157-1037
Brad Jones, R. http://orcid.org/0000-0003-4470-1231
Mothe, Beatriz http://orcid.org/0000-0001-9975-407X
Brander, Christian http://orcid.org/0000-0002-0548-5778
Fox, Julie http://orcid.org/0000-0002-0583-8019
Nussenzweig, Michel C. http://orcid.org/0000-0003-0592-8564
Fidler, Sarah
Caskey, Marina http://orcid.org/0000-0003-1727-8693
Tolstrup, Martin
Søgaard, Ole S. http://orcid.org/0000-0001-9107-2023
Funding for this research was provided by:
Det Frie Forskningsråd (7016-00022, 9060-00023B)
Article History
Received: 15 August 2022
Accepted: 14 October 2022
First Online: 29 October 2022
Competing interests
: M.C.N. is listed as an inventor on patents for the antibody 3BNC117. All other authors declare no competing interests.